Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia

Table 1

CLL patients.

Samples	Sex	Age	Proliferation center	13q deletion	CD38	ZAP-70	%Ki-67
1	M	60	0	Yes	1	0	15
2	M	81	0	Yes	5	4	2.5
3	M	81	0	Yes	0	3	15
4	M	59	1	Yes	0	5	90
5	M	76	0	Yes	5	n.e	10
6	F	75	1	Yes	0	0	20
7	M	70	1	Yes	0	n.e	17.5
8	M	66	0	Yes	3	5	5
9	F	73	1	Yes	0	n.e	27.5
10	M	63	0	Yes	0	n.e	17.5
11	F	68	1	Yes	0	5	25
12	M	56	0	Yes	0	5	5
13	M	75	1	Yes	4	5	25
14	M	62	1	Yes	0	0	20
15	M	72	1	Yes	5	5	20
16	M	47	1	Yes	2	3	27.5
17	M	62	0	Yes	0	5	55
18	M	58	0	Yes	0	4	15
19	F	56	0	Yes	0	5	5
20	F	73	0	Yes	0	5	5
21	M	70	1	No	0	2	35
22	M	53	0	No	0	4	15
23	F	78	1	No	2	4	17.5
24	M	66	0	No	0	0	2.5
25	M	71	0	No	1	0	50
26	F	75	1	No	0	0	70
27	F	76	0	No	0	4	n.e
28	M	55	0	No	0	5	15
29	M	45	0	No	n.e	4	15
30	F	80	1	No	0	0	35
31	M	74	0	No	0	0	25
32	M	70	0	No	0	1	5
33	M	64	0	No	5	5	15
34	M	58	1	No	0	5	70
35	M	74	0	No	0	1	12.5
36	M	71	1	No	0	4	20
37	F	57	0	No	2	0	60
38	M	55	0	No	0	0	12.5
39	M	79	0	No	4	n.e	n.e
40	F	73	1	No	0	n.e	15

Proliferation center: (1) rich, (0) typical.
CD38 and ZAP70 categories: (1) <10%, (2) 10–15%, (3) 25–50%, (4) 50–75%, (5) >75%.